Skip to content

Reflexo Therapy for Gestational Diabetes Mellitus

The Effects of Reflexo Therapy of Sole on Gestational Diabetes Mellitus

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06976164
Enrollment
36
Registered
2025-05-16
Start date
2025-05-01
Completion date
2026-06-01
Last updated
2025-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Therapy

Keywords

Gestational diabetes mellitus, Foot reflexology, Fasting plasma glucose, 2-h post-prandial glucose, HbA1c

Brief summary

The purpose of this study will be to detect the effects of Reflexo therapy of sole on GDM.

Detailed description

Gestational diabetes mellitus is considered a hazard factor for antenatal complications for both mother and fetus. It is characterized by glucose intolerance of variable degrees with the beginning or first recognition of pregnancy. It affects 14% of pregnancies worldwide, and it undergoes continuous changes in the diagnostic criteria, ethnicity and the population studied. There is an increasing prevalence of diabetes mellitus, and its major metabolic disorder caused by the insulin secretion defect or insulin action defect resulting from a defect in insulin secretion, insulin action, or both. As a result, it will lead to chronic hyperglycemia associated with carbohydrates, protein, and fat disturbance. In spite of the fact that the reason for gestational diabetes mellitus is still not fully understood, it is proposed that human placental lactogen has growth hormone-like actions, and that it causes lipolysis and thus increases the levels of circulating fatty acids that repress the action of insulin and cause insulin resistance in pregnant females which appear to play a crucial role in the pathogenesis of gestational diabetes mellitus.

Interventions

PROCEDUREThe standard antenatal care.

Antenatal Protocol.

PROCEDUREFoot reflexology.

A manual therapy technique.

Sponsors

Kafrelsheikh University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

1. They were maternally aged between 20 and 35 years. 2. The gestational age ranged from between 24 and 36 weeks. 3. Their BMI didn't exceed 30 kg/m2. 4. A singleton live fetus and not under stressful event.

Exclusion criteria

1. They had high-risk pregnancies. 2. Bad obstetric situations. 3. Diseases that could interfere with participation. 4. Smoking. 5. Oral sedative administration.

Design outcomes

Primary

MeasureTime frame
Change in The Oral Glucose Tolerance Test.Change from Baseline Oral Glucose Tolerance Test at one month
Change in The Hemoglobin A1C Test.Change from Baseline Hemoglobin A1C Test at one month

Countries

Egypt

Contacts

Primary ContactYomna E Ghanem, M.Sc.
youmna.ezz_a012@pt.kfs.edu.eg+201011501343
Backup ContactFayiz F Elshamy, PhD
fayez_elshamy2014@pt.kfs.edu.eg+201091050154

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026